Document is current
Any future updates will be listed below
-
Authors
Pearson, Joshua R. D. https://orcid.org/0000-0003-1687-5955
Puig-Saenz, Carles https://orcid.org/0000-0002-0158-9529
Thomas, Jubini E.
Hardowar, Lydia D. https://orcid.org/0000-0001-6890-4020
Ahmad, Murrium https://orcid.org/0000-0002-6074-2001
Wainwright, Louise C.
McVicar, Adam M.
Brentville, Victoria A.
Tinsley, Chris J. https://orcid.org/0000-0002-9369-443X
Pockley, A. Graham https://orcid.org/0000-0001-9593-6431
Durrant, Lindy G.
McArdle, Stephanie E. B. https://orcid.org/0000-0001-6929-9782
-
Funding
Funding for this research was provided by:
Headcase Cancer Trust
- License Information
-
More Information
Article History
Received: 3 January 2024
Accepted: 25 June 2024
First Online: 2 July 2024
Declarations
:
: Author LD is a director and shareholder of Scancell Ltd and is a named inventor of the ImmunoBody® patents; she declares no non-financial competing interests. All other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
